{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:36Z","timestamp":1758979296058,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS092912","K08NS081105"],"award-info":[{"award-number":["K08NS092912","K08NS081105"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-58-010-58-1","ACS-IRG-58-010-57"],"award-info":[{"award-number":["IRG-58-010-58-1","ACS-IRG-58-010-57"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duesenberg Research Fund"},{"name":"Physician Scientist Training Program"},{"DOI":"10.13039\/100012131","name":"Brain Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10014-016-0257-5","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T06:07:49Z","timestamp":1457503669000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["High incidence of TERT mutation in brain tumor cell lines"],"prefix":"10.1007","volume":"33","author":[{"given":"Tanner M.","family":"Johanns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale K.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane D.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-4834","authenticated-orcid":false,"given":"Gavin P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"issue":"10","key":"257_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"7216","key":"257_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"TCGA Network","year":"2008","unstructured":"Network TCGA (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061\u20131068","journal-title":"Nature"},{"issue":"2","key":"257_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW et al (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462\u2013477","journal-title":"Cell"},{"issue":"5897","key":"257_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807\u20131812","journal-title":"Science"},{"issue":"6743","key":"257_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/22780","volume":"400","author":"WC Hahn","year":"1999","unstructured":"Hahn WC et al (1999) Creation of human tumour cells with defined genetic elements. Nature 400(6743):464\u2013468","journal-title":"Nature"},{"issue":"3","key":"257_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc3025","volume":"11","author":"P Martinez","year":"2011","unstructured":"Martinez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11(3):161\u2013176","journal-title":"Nat Rev Cancer"},{"issue":"5193","key":"257_CR7","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011\u20132015","journal-title":"Science"},{"issue":"6122","key":"257_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW et al (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339(6122):957\u2013959","journal-title":"Science"},{"issue":"6238","key":"257_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.aab0015","volume":"348","author":"RJ Bell","year":"2015","unstructured":"Bell RJ et al (2015) Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 348(6238):1036\u20131039","journal-title":"Science"},{"issue":"15","key":"257_CR10","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ et al (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110(15):6021\u20136026","journal-title":"Proc Natl Acad Sci USA"},{"key":"257_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","volume":"24","author":"B Heidenreich","year":"2014","unstructured":"Heidenreich B et al (2014) TERT promoter mutations in cancer development. Curr Opin Genet Dev 24:30\u201337","journal-title":"Curr Opin Genet Dev"},{"issue":"12","key":"257_CR12","doi-asserted-by":"publisher","first-page":"10617","DOI":"10.18632\/oncotarget.3329","volume":"6","author":"B Heidenreich","year":"2015","unstructured":"Heidenreich B et al (2015) TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. Oncotarget 6(12):10617\u201310633","journal-title":"Oncotarget"},{"issue":"13","key":"257_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.0000000000000814","volume":"83","author":"M Labussiere","year":"2014","unstructured":"Labussiere M et al (2014) Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes. Neurology 83(13):1200\u20131206","journal-title":"Neurology"},{"issue":"7391","key":"257_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J et al (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607","journal-title":"Nature"},{"issue":"11","key":"257_CR15","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.celrep.2015.05.027","volume":"11","author":"DD Mao","year":"2015","unstructured":"Mao DD et al (2015) A CDC20-APC\/SOX2 signaling axis regulates human glioblastoma stem-like cells. Cell Rep 11(11):1809\u20131821","journal-title":"Cell Rep"},{"issue":"26","key":"257_CR16","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499\u20132508","journal-title":"N Engl J Med"},{"issue":"1","key":"257_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/neuonc\/nou158","volume":"17","author":"M Simon","year":"2015","unstructured":"Simon M et al (2015) TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Neuro Oncol 17(1):45\u201352","journal-title":"Neuro Oncol"},{"key":"257_CR18","doi-asserted-by":"publisher","unstructured":"Sahm F et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst 108(5). doi:\n                    10.1093\/jnci\/djv377","DOI":"10.1093\/jnci\/djv377"},{"issue":"2","key":"257_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S et al (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24(2):184\u2013189","journal-title":"Brain Pathol"},{"issue":"26","key":"257_CR20","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"Cancer Genome Atlas Research network","year":"2015","unstructured":"Cancer Genome Atlas Research network et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372(26):2481\u20132498","journal-title":"N Engl J Med"},{"issue":"20","key":"257_CR21","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1073\/pnas.182407599","volume":"99","author":"SA Stewart","year":"2002","unstructured":"Stewart SA et al (2002) Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99(20):12606\u201312611","journal-title":"Proc Natl Acad Sci USA"},{"key":"257_CR22","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1038\/oncsis.2015.39","volume":"4","author":"FW Huang","year":"2015","unstructured":"Huang FW et al (2015) TERT promoter mutations and monoallelic activation of TERT in cancer. Oncogenesis 4:e176","journal-title":"Oncogenesis"},{"issue":"5","key":"257_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jamaoncol.2015.0917","volume":"1","author":"GM Shankar","year":"2015","unstructured":"Shankar GM et al (2015) Rapid intraoperative molecular characterization of glioma. JAMA Oncol 1(5):662\u2013667","journal-title":"JAMA Oncol"},{"issue":"2","key":"257_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H et al (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126(2):267\u2013276","journal-title":"Acta Neuropathol"},{"issue":"6088","key":"257_CR25","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1223785","volume":"336","author":"CW Greider","year":"2012","unstructured":"Greider CW (2012) Molecular biology. Wnt regulates TERT\u2014putting the horse before the cart. Science 336(6088):1519\u20131520","journal-title":"Science"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-016-0257-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0257-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:02:05Z","timestamp":1589450525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-016-0257-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1007\/s10014-016-0257-5","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"type":"print","value":"1433-7398"},{"type":"electronic","value":"1861-387X"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"assertion":[{"value":"4 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}